tbuckley/cabot-search huggingface dataset:
The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review
Authors: Laura N Broyles, Robert Luo, Debi Boeras, Lara Vojnov
Journal: The Lancet (2023)

The risk of sexual transmission of HIV from individuals with low-level HIV viraemia receiving antiretroviral therapy (ART) has important public health implications, especially in resource-limited settings that use alternatives to plasma-based viral load testing. This Article summarises the evidence related to sexual transmission of HIV at varying HIV viral load levels to inform messaging for people living with HIV, their partners, their health-care providers, and the wider public.We conducted a systematic review and searched PubMed, MEDLINE, Cochrane Central Register of Controlled Trials, Embase, Conference Proceedings Citation Index-Science, and WHO Global Index Medicus, for work published from Jan 1, 2010 to Nov 17, 2022. Studies were included if they pertained to sexual transmission between serodiscordant couples at various levels of viraemia, the science behind undetectable=untransmittable, or the public health impact of low-level viraemia. Studies were excluded if they did not specify viral load thresholds or a definition for low-level viraemia or did not provide quantitative viral load information for transmission outcomes. Reviews, non-research letters, commentaries, and editorials were excluded. Risk of bias was evaluated using the ROBINS-I framework. Data were extracted and summarised with a focus on HIV sexual transmission at varying HIV viral loads.244 studies were identified and eight were included in the analysis, comprising 7762 serodiscordant couples across 25 countries. The certainty of evidence was moderate; the risk of bias was low. Three studies showed no HIV transmission when the partner living with HIV had a viral load less than 200 copies per mL. Across the remaining four prospective studies, there were 323 transmission events; none were in patients considered stably suppressed on ART. Among all studies there were two cases of transmission when the index patient's (ie, patient with previously diagnosed HIV infection) most recent viral load was less than 1000 copies per mL. However, interpretation of both cases was complicated by long intervals (ie, 50 days and 53 days) between the transmission date and the most recent index viral load result.There is almost zero risk of sexual transmission of HIV with viral loads of less than 1000 copies per mL. These data provide a powerful opportunity to destigmatise HIV and promote adherence to ART through dissemination of this positive public health message. These findings can also promote access to viral load testing in resource-limited settings for all people living with HIV by facilitating uptake of alternative sample types and technologies.Bill & Melinda Gates Foundation.
A cortico-amygdala neural substrate for endocannabinoid modulation of fear extinction
Authors: Ozge Gunduz-Cinar, Laura I. Castillo, Maya Xia, Elise Van Leer, Emma T. Brockway, Gabrielle A. Pollack, Farhana Yasmin, Olena Bukalo, Aaron Limoges, Sarvar Oreizi-Esfahani, Veronika Kondev, Rita Báldi, Ao Dong, Judy Harvey-White, Resat Cinar, George Kunos, Yulong Li, Larry S. Zweifel, Sachin Patel, Andrew Holmes
Journal: Neuron (2023)
Nucleocytoplasmic mRNA redistribution accompanies RNA binding protein mislocalization in ALS motor neurons and is restored by VCP ATPase inhibition
Authors: Oliver J. Ziff, Jasmine Harley, Yiran Wang, Jacob Neeves, Giulia Tyzack, Fairouz Ibrahim, Mark Skehel, Anob M. Chakrabarti, Gavin Kelly, Rickie Patani
Journal: Neuron (2023)

Amyotrophic lateral sclerosis (ALS) is characterized by nucleocytoplasmic mislocalization of the RNA-binding protein (RBP) TDP-43. However, emerging evidence suggests more widespread mRNA and protein mislocalization. Here, we employed nucleocytoplasmic fractionation, RNA sequencing, and mass spectrometry to investigate the localization of mRNA and protein in induced pluripotent stem cell-derived motor neurons (iPSMNs) from ALS patients with TARDBP and VCP mutations. ALS mutant iPSMNs exhibited extensive nucleocytoplasmic mRNA redistribution, RBP mislocalization, and splicing alterations. Mislocalized proteins exhibited a greater affinity for redistributed transcripts, suggesting a link between RBP mislocalization and mRNA redistribution. Notably, treatment with ML240, a VCP ATPase inhibitor, partially restored mRNA and protein localization in ALS mutant iPSMNs. ML240 induced changes in the VCP interactome and lysosomal localization and reduced oxidative stress and DNA damage. These findings emphasize the link between RBP mislocalization and mRNA redistribution in ALS motor neurons and highlight the therapeutic potential of VCP inhibition.
Lactate modulates iron metabolism by binding soluble adenylyl cyclase
Authors: Wei Liu, Shuping Zhang, Quanjin Li, Yue Wu, Xuan Jia, Wenya Feng, Zhaolong Li, Yali Shi, Qingzhi Hou, Juan Ma, Yajun Liu, Pu Gao, Tomas Ganz, Sijin Liu
Journal: Cell Metabolism (2023)
The role of syphilis self-testing as an additional syphilis testing approach in key populations: a systematic review and meta-analysis
Authors: Janet M Towns, Warittha Tieosapjaroen, Maeve B Mello, Rachel C Baggaley, Cheryl C Johnson, Muhammad S Jamil, Jane Rowley, Magdalena Barr-DiChiara, Fern Terris-Prestholt, Marcus Y Chen, Eric P F Chow, Christopher K Fairley, Lei Zhang, Jason J Ong
Journal: The Lancet Public Health (2023)

Syphilis is causing epidemics in many countries. Syphilis self-testing (SST) has potential to increase testing and treatment coverage in the same manner as documented for self-testing of, for example, HIV, hepatitis C virus, and COVID-19. We aimed to synthesise current evidence on the utility of SST.We conducted a systematic review and, where possible, meta-analysis. We searched MEDLINE, Embase, CINAHL, Scopus, and Web of Science for publications published from Jan 1, 2000, to Oct 13, 2022. We included publications with original data on any syphilis rapid tests, including dual HIV-syphilis tests. Study populations were not restricted. We used random-effects meta-analysis to calculate the pooled proportion of people offered SST who undertook the test. The systematic review was registered in PROSPERO (CRD42022302129).In total, 40 499 citations were identified. 11 publications from seven studies from the USA, Zimbabwe, and China met eligibility criteria. Of those, four studies reported data from men who have sex with men and five studies used dual HIV-SST. Using data from one randomised controlled trial and three observational studies, the pooled proportion of people who received SST kits who undertook the test was 88% (95% CI 85-91). No studies provided data on the sensitivity or specificity of SST. Overall, user and provider preference for SST was high, with participants reporting convenience, privacy, rapid results, autonomy, trust in blood-based tests, decreased facility contact, and time savings, with individuals being able to correctly self-test. Publications from China reported that SST had lower costs per person tested than existing facility-based testing options.Our review builds on the literature for self-testing across different disease areas and demonstrates that SST has the potential to reach underserved populations. As this review found that SST use was acceptable and feasible to implement, SST can be used as an additional syphilis testing approach. Since no data on the sensitivity and specificity of SST were found, further implementation research will be required to guide the best strategies for SST service delivery and future scale-up.WHO, Australian National Health and Medical Research Council, and Unitaid.
Targeting phenylpyruvate restrains excessive NLRP3 inflammasome activation and pathological inflammation in diabetic wound healing
Authors: Dongming Lv, Xiaoling Cao, Li Zhong, Yunxian Dong, Zhongye Xu, Yanchao Rong, Hailin Xu, Zhiyong Wang, Hao Yang, Rong Yin, Miao Chen, Chao Ke, Zhicheng Hu, Wuguo Deng, Bing Tang
Journal: Cell Reports Medicine (2023)

Moderate inflammation is essential for standard wound healing. In pathological conditions, such as diabetes, protracted and refractory wounds are associated with excessive inflammation, manifested by persistent proinflammatory macrophage states. However, the mechanisms are still unclear. Herein, we perform a metabolomic profile and find a significant phenylpyruvate accumulation in diabetic foot ulcers. Increased phenylpyruvate impairs wound healing and augments inflammatory responses, whereas reducing phenylpyruvate via dietary phenylalanine restriction relieves uncontrolled inflammation and benefits diabetic wounds. Mechanistically, phenylpyruvate is ingested into macrophages in a scavenger receptor CD36-dependent manner, binds to PPT1, and inhibits depalmitoylase activity, thus increasing palmitoylation of the NLRP3 protein. Increased NLRP3 palmitoylation is found to enhance NLRP3 protein stability, decrease lysosome degradation, and promote NLRP3 inflammasome activation and the release of inflammatory factors, such as interleukin (IL)-1β, finally triggering the proinflammatory macrophage phenotype. Our study suggests a potential strategy of targeting phenylpyruvate to prevent excessive inflammation in diabetic wounds.
Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity
Authors: Motoko Koyama, Daniel S. Hippe, Sujatha Srinivasan, Sean C. Proll, Oriana Miltiadous, Naisi Li, Ping Zhang, Kathleen S. Ensbey, Noah G. Hoffman, Christine R. Schmidt, Albert C. Yeh, Simone A. Minnie, Susan M. Strenk, Tina L. Fiedler, Namita Hattangady, Jacob Kowalsky, Willian M. Grady, Mariapia A. Degli-Esposti, Antiopi Varelias, Andrew D. Clouston, Marcel R.M. van den Brink, Neelendu Dey, Timothy W. Randolph, Kate A. Markey, David N. Fredricks, Geoffrey R. Hill
Journal: Immunity (2023)
A clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial
Authors: Xinrong Zhang, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Wei-Xuan Leow, Yan Liang, Lee-Ling Lim, Guanlin Li, Luqman Ibrahim, Huapeng Lin, Che To Lai, Henry LY Chan, Alice Pik-Shan Kong, Wah-Kheong Chan, Vincent Wai-Sun Wong
Journal: Journal of Hepatology (2023)
Hemoglobin is a short-term prognostic factor in decompensated alcohol-associated cirrhosis: a multicenter prospective study
Authors: José Ursic Bedoya, Claire Espérance, Safia Aouinti, Ludovic Caillo, Magdalena Meszaros, Marie Pierre Ripault, Laura Jaubert, Adrien Ardavan Prost, Lucy Meunier, Stéphanie Faure, Cathy Soulayrac, Hélène Donnadieu, Boris Guiu, Nicolas Molinari, Jérôme Dumortier, Georges-Philippe Pageaux
Journal: Journal of Hepatology (2023)
The new diagnostic criteria of portopulmonary hypertension identify a group of patients with cirrhosis at high risk of death
Authors: Luis Téllez, Antonio Guerrero, Jesus Donate, Miguel Ángel Rodríguez-Gandía, Susana del Prado, Andrés Tenes, Rosa Martin-Mateos, Rosario González Alonso, Javier Martinez, Miguel García González, Rubén Sánchez-Aldehuelo, Diego Burgos Santamaria, Beatriz Mateos Muños, María Torres Guerrero, Jose Luis Lledo Navarro, Agustin Albillos
Journal: Journal of Hepatology (2023)
Targeting myeloid-derived suppressor cells in a carbon tetrachloride-induced murine model of chronic liver injury
Authors: Emilio Flint, Caner Ercan, Lucia Possamai, Evangelos Triantafyllou, Christine Bernsmeier, Emilio Flint, Caner Ercan, Lucia Possamai, Evangelos Triantafyllou, Christine Bernsmeier
Journal: Journal of Hepatology (2023)
Control compounds used to validate in vitro models of idiosyncratic drug-induced liver injury: a systematic review
Authors: Antonio Segovia-Zafra, Marina Villanueva, Ana Serras, Gonzalo Matilla, Ana Bodoque-García, Daniel E. Di Zeo-Sánchez, Hao Niu, Ismael Alvarez-Alvarez, Sergej Godec, Irina Milisav, José Fernandez-Checa, Maria Isabel Lucena, Francisco Javier Cubero, Joana Miranda, Leonard J Nelson, Raul J. Andrade
Journal: Journal of Hepatology (2023)
A gene editing approach for chronic hepatitis B: elimination of hepatitis B virus in vivo by targeting cccDNA and integrated viral genomes with a sequence-specific ARCUS nuclease
Authors: Cassandra Gorsuch, Paige Nemec, Mei Yu, Simin Xu, Dong Han, Jeff Smith, Janel Lape, Nicholas Van Buuren, Ricardo Ramirez, Robert Muench, Meghan Holdorf, Becket Feierbach, Greg Falls, Jason Holt, Wendy Shoop, Emma Sevigny, Forrest Karriker, Robert Brown, Amod Joshi, Tyler Goodwin, Ying Tam, Paulo Lin, Sean Semple, Neil Leatherbury, William E. Delaney, Derek Jantz, Emily Harrison, Amy Rhoden Smith
Journal: Journal of Hepatology (2023)
Terlipressin has acute effects on systemic inflammation markers in patients with cirrhosis and ascites
Authors: Nikolaj Torp, Mads Israelsen, Emil Deleuran Hansen, Stine Johansen, Camilla Dalby Hansen, Emilie Dahl, Bjørn Stæhr Madsen, Johanne Kragh Hansen, Katrine Prier Lindvig, Katrine Thorhauge, Katrine Bech, Ida Villesen, Ellen Jensen, Ida Ziegler Spedtsberg, Peter Andersen, Annette Fialla, Boye Jensen, Maja Thiele, Sabine Klein, Robert Schierwagen, Jonel Trebicka, Aleksander Krag
Journal: Journal of Hepatology (2023)
Correlation between mid-arm circumference and QRS alterations as markers of sarcopenia in patients with decompensated cirrhosis
Authors: Letitia Toma, Codruta Radu, Adriana Mercan-Stanciu, Teodora Isac, Mihai Dodot, Mircea Istrate, Razvan Rababoc, Elena Laura Iliescu
Journal: Journal of Hepatology (2023)
Rotational Thromboelastometry (ROTEM) reduces need for pre-emptive transfusion in low-moderate risk procedure in cirrhosis: a randomized controlled trial
Authors: Chin Kimg Tan, Louis Ng, Eugene Wong, Kenneth Lin, Andrew Kwek, James Weiquan Li, Tiing Leong Ang, Louis Wang, Tianyu Qiu, Roshni Sahashiv, Tirukonda Prasanna Sivanath, Rahul Kumar
Journal: Journal of Hepatology (2023)
Predictors of clinical courses in patients wih acutely decompensated cirrhosis. An external validation of the PREDICT study
Authors: Enrico Pompili, Maurizio Baldassarre, Giorgio Bedogni, Giacomo Zaccherini, Giulia Iannone, Clara De Venuto, Francesco Palmese, Manuel Tufoni, Marco Domenicali, Paolo Caraceni
Journal: Journal of Hepatology (2023)
Investigating the PD-1/PD-L pathway and macrophage responses in acute-on-chronic liver failure
Authors: Dimitrios Patseas, Eoin Mitchell, Emilio Flint, Tong Liu, Sujit Mukherjee, Lucia Possamai, Mark J W McPhail, Christine Bernsmeier, Evangelos Triantafyllou
Journal: Journal of Hepatology (2023)
Low sphingolipid levels indicate poor survival in patients with alcohol-related liver disease
Authors: Thit Mynster Kronborg, Qian Gao, Kajetan Trost, Henriette Ytting, Malene Barfod O’Connell, Mikkel Werge, Mira Thing, Lise Lotte Gluud, Søren Møller, Thomas Moritz, Flemming Bendtsen, Nina Kimer
Journal: Journal of Hepatology (2023)
Vitamin D deficiency associates with gut dysbiosis, endotoxemia and the risk of infectious complications in patients with liver cirrhosis
Authors: Pei-Chang Lee, Kuei-Chuan Lee, Hsiao-Sheng Lu, Yu-Jen Chen, Tsung-Yi Cheng, Tsung-Chieh Yang, Jen-Jie Chiou, Chi-Wei Huang, Ueng-Cheng Yang, Yi-Hsiang Huang, Ming-Chih Hou
Journal: Journal of Hepatology (2023)
X-box binding protein 1 (XBP1) in hepatic stellate cells (HSC) mitigates liver fibrosis
Authors: Hanghang Wu, Hui Ye, Juan Francisco Vilchez-Gómez, Marcos Fernandez Fondevila, Aveline Filliol, Robert F. Schwabe, Javier Vaquero, Rafael Bañares, Ruben Nogueiras, Eduardo Martínez-Naves, Scott Friedman, Yulia Nevzorova, Francisco Javier Cubero
Journal: Journal of Hepatology (2023)
ε-Lysine-melittin reduces pathological bacterial translocation and enhances gut immunity in experimental decompensated cirrhosis
Authors: Deepika Jakhar, Pinky Juneja, Aarti Sharma, Impreet Kaur, Dinesh Mani Tripathi, Lakshminarayanan Rajamani, Savneet Kaur
Journal: Journal of Hepatology (2023)
A multimodal treatment candidate for sarcopenia in men with decompensated cirrhosis: a randomized, placebo-controlled trial evaluating LPCN 1148
Authors: Benjamin Bruno, Josh Weavil, Jonathan Ogle, George Nomikos, Anthony DelConte, Nachaippan Chidambaram, Mahesh Patel, Jennifer Lai, Arun Sanyal
Journal: Journal of Hepatology (2023)
Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
Authors: Ohad Etzion, Saeed Sadiq Hamid, Tarik Asselah, George Sebastian Gherlan, Adela Turcanu, Tsarynna Petrivna, Lisa Weissfeld, Ingrid Choong, Colin Hislop, David Apelian, Maria Buti, Liana Gheorghe, Elena Laura Iliescu, Natalia Voronkova, Natalia Barsukova, Soo Aleman, Jordan J. Feld, Nancy S Reau, Maurizia Brunetto, Pietro Lampertico, Theo Heller, Chris Koh, Cihan Yurdaydin, Jeffrey Glenn
Journal: Journal of Hepatology (2023)
Distinct patterns of hepatic and systemic inflammation in different types/aetiologies of liver disease
Authors: Benedikt Hofer, Benedikt Simbrunner, Philipp Königshofer, Kerstin Zinober, Georg Semmler, Thomas Sorz, Vlad Taru, Mattias Mandorfer, Michael Trauner, Philipp Schwabl, Thomas Reiberger
Journal: Journal of Hepatology (2023)
Smoking and obesity promote systemic inflammation in patients with compensated and decompensated cirrhosis
Authors: Benedikt Hofer, Benedikt Simbrunner, Georg Semmler, Michael Schwarz, Lorenz Balcar, Lukas Hartl, Mathias Jachs, Katharina Pomej, Rafael Paternostro, Theresa Müllner-Bucsics, Philipp Schwabl, Bernhard Scheiner, Michael Trauner, Mattias Mandorfer, Thomas Reiberger
Journal: Journal of Hepatology (2023)
Long-term efficacy of tenofovir alafenamide in HBeAg-positive and -negative chronic hepatitis B patients treated for up to 8 years in 2 phase 3 studies
Authors: Maria Buti, Kosh Agarwal, Henry Ly Chan, Wai-Kay Seto, Young-Suk Lim, Maurizia Brunetto, Wan-Long Chuang, Harry Janssen, Scott Fung, Namiki Izumi, Maciej Jablkowski, Frida Abramov, Hongyuan Wang, Leland Yee, Roberto Mateo, John F. Flaherty, Calvin Pan, None Shalimar, Patrick Marcellin, Edward J. Gane
Journal: Journal of Hepatology (2023)
Plasma multi-omics outlines association of urobilinogen with corticosteroid non-response, inflammation, intestinal permeability and outcome in severe alcoholic hepatitis
Authors: Jaswinder Maras, Manisha Yadav, Babu Mathew, Sadam H Bhat, Neha Sharma, Gaurav Tripathi, Nupur Sharma, Vasundhra Bindal, Sushmita Pandey, Jitendra Kumar, Pushpa Yadav, Ravinder Singh, Mojahidul Islam, Ashima Bhaskar, Ved Dwivedi, Nirupma Trehanpati, Shvetank Sharma, Shiv Kumar Sarin
Journal: Journal of Hepatology (2023)
Acute on chronic liver failure is associated with prolonged clot initiation in rotational thromboelastometry as compared to acute decompensation, but clot formation time and firmness are similar
Authors: Tian Yu Qiu, Louis Wang, Chin Kimg Tan, Eugene Wong, Kenneth Lin, Andrew Kwek, James Weiquan Li, Tiing Leong Ang, Roshni Sahashiv, Louis Ng, Prasanna Tirukonda, Rahul Kumar
Journal: Journal of Hepatology (2023)
Gender differences in repair mechanisms of chronic cholangiopathies with progressive fibrosis
Authors: Massimiliano Cadamuro, Labjona Haxhiaj, Chiara Montanaro, Erica Villa, Annarosa Floreani, Nora Cazzagon, Giovannella Baggio, Mario Strazzabosco, Paolo Simioni, Luca Fabris
Journal: Journal of Hepatology (2023)
Predictors of severe flares after nucleos (t)ide analogue cessation-results of a global cohort study (RETRACT-B study)
Authors: Edo Dongelmans, Grishma Hirode, Bettina Hansen, Chien-Hung Chen, Tung-Hung Su, Wai-Kay Seto, Arno Furquim d’Almeida, Stijn Van Hees, Margarita Papatheodoridi, Sabela Lens, Grace Wong, Sylvia Brakenhoff, Rong-Nan Chien, Jordan J. Feld, Henry Ly Chan, Xavier Forns, George Papatheodoridis, Thomas Vanwolleghem, Man-Fung Yuen, Yao-Chun (Holden) Hsu, Jia-Horng Kao, Markus Cornberg, Milan Sonneveld, Rachel Wen-Juei Jeng, Harry LA Janssen
Journal: Journal of Hepatology (2023)
MELD-sarcopenia and clinically significant portal hypertension as independent risk factors in the evolution of liver cirrhosis
Authors: Elba Llop, Marta Hernández Conde, Marta López-Gómez, Christie Perelló, Carlos Fernández-Carrillo, Javier Abad, Jesús Rivera, José Luis Martínez Porras, Natalia Fernández Puga, Maria Trapero, Enrique Fraga, José Luis Calleja Panero
Journal: Journal of Hepatology (2023)
A virtual reality-driving test to predict car accidents in patients with cirrhosis
Authors: Simon Johannes Gairing, Eva Maria Schleicher, Leonard Kaps, Sophia Schulte-Beerbuehl, Kristina Steiner, Joachim Labenz, Jörn Schattenberg, Peter Galle, Marcus-Alexander Wörns, Christian Labenz
Journal: Journal of Hepatology (2023)
Efficacy of N-acetylcysteine to prevent anti-tuberculosis drug-induced liver injury: a randomized controlled trial
Authors: Supot Nimanong, Kittichai Samaithongcharoen, Watcharasak Chotiyaputta, Suppareark Disayabutr, Phunchai Charatcharoenwitthaya, Siwaporn Chainuvati, Tawesak Tanwandee
Journal: Journal of Hepatology (2023)
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS)
Authors: Michael Trauner, Cynthia Levy, Atsushi Tanaka, Zachary Goodman, Douglas Thorburn, Deepak Joshi, Kimmo Salminen, Kidist Yimam, Hiroyuki Isayama, Aldo J Montano-Loza, Mark Danta, Holger Hinrichsen, Pietro Invernizzi, Xiangyu Liu, Xiaomin Lu, Muhsen Alani, William Barchuk, Timothy R. Watkins, Mark Genovese, Christopher Bowlus
Journal: Journal of Hepatology (2023)
Safety and efficacy of continuous infusion terlipressin in acute kidney injury-hepatorenal syndrome: the Infuse study
Authors: K. Rajender Reddy, Ethan Weinberg, Stevan Gonzalez, Manhal Izzy, Douglas Simonetto, Richard Frederick, Raymond Rubin, Zachary Fricker, Grace Kim-Lee, Sherry Witkiewicz, William Tobin, Khurram Jamil
Journal: Journal of Hepatology (2023)
Artificial intelligence to measure fibrosis change on liver biopsy in MAESTRO-NASH a phase 3 52-week serial liver biopsy study in 966 patients with NASH treated with resmetirom or placebo
Authors: Stephen Harrison, Rebecca Taub, Dominic Labriola, Yayun Ren, Elaine Chng, Dean Tai
Journal: Journal of Hepatology (2023)
Current prognosis of gastric variceal bleeding in France: preliminary results from a multicenter prospective cohort of 87 cirrhotic patients
Authors: Delphine Weil-Verhoeven, Jean Paul Cervoni, Frédéric Oberti, Alexandre Louvet, Louis D’alteroche, Stéphanie Faure, Marianne Latournerie, Nicolas Carbonell, Caroline Jezequel, Claire Billioud, Faouzi Saliba, Charlotte Bouzbib, Florence Tanne, Isabelle Ollivier-Hourmand, Hiriart Jean-Baptiste, Faiza Chermak, Sophie-Caroline Sacleux, Laure Elkrief, Agnès Rode, Gerster Théophile, Isabelle Mabile-Archambeaud, Eric Nguyen Khac, Ludivine Legros, Lannes Adrien, Marie-Angèle Robic, Patrick Borentain, Maxime Desmarets, Dominique Thabut, Vincent Di Martino, Marika Rudler, Christophe Bureau
Journal: Journal of Hepatology (2023)
Plasma lipidomics and meta-proteomics analysis classifies lipid species and microbial peptides associated with poor outcome in SAH patients
Authors: Jaswinder Maras, Manisha Yadav, Nupur Sharma, Gaurav Tripathi, Babu Mathew, Vasundhra Bindal, Neha Sharma, Sushmita Pandey
Journal: Journal of Hepatology (2023)
Acute kidney injury related to metamizole in advanced chronic liver disease patients undergoing major orthopedic surgery
Authors: Lidia Canillas, Amalia Pelegrina, Elena Colominas, Aina Salis, César Jessé Enríquez-Rodríguez, Antonia Caro, Marc Puigvehí, Teresa Broquetas, Susana Coll, NURIA Cañete, Montserrat García-Retortillo, Xavier Bessa, Juan Carlos Álvarez, Jose A. Carrión
Journal: Journal of Hepatology (2023)
Is elastography needed for diagnosing cACLD and stratifying CSPH risk?
Authors: Georg Semmler, Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, Benedikt Hofer, Lorenz Balcar, Michael Schwarz, Laurenz Fritz, Anna Schedlbauer, Katharina Stopfer, Daniela Neumayer, Jurij Maurer, Robin Szymanski, Bernhard Scheiner, Michael Trauner, Thomas Reiberger, Mattias Mandorfer
Journal: Journal of Hepatology (2023)